Clinical Trials Logo

Advanced Soft Tissue Sarcoma clinical trials

View clinical trials related to Advanced Soft Tissue Sarcoma.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT03838744 Active, not recruiting - Clinical trials for Advanced Soft Tissue Sarcoma

Randomized Trial in Advanced, Metastatic or Unresectable Soft Tissue Sarcoma After Failure of Standard Treatments.

TOMAS2
Start date: May 26, 2020
Phase: Phase 2
Study type: Interventional

Phase II study in patient with advanced Soft Tissue Sarcoma (STS) patients who have already received or are not suitable, for a doxorubicin-based treatment.

NCT ID: NCT03660930 Active, not recruiting - Clinical trials for Metastatic Soft Tissue Sarcoma

Nab-Sirolimus and Pazopanib Hydrochloride in Treating Patients With Advanced Nonadipocytic Soft Tissue Sarcomas

Start date: April 1, 2019
Phase: Phase 1/Phase 2
Study type: Interventional

This phase I/II trial studies the side effects and best dose of nab-sirolimus and how well it works when given together with pazopanib hydrochloride in treating participants with nonadipocytic soft tissue sarcomas that has spread to other places in the body (advanced). Nab-sirolimus and pazopanib hydrochloride may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.